Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT02625870
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 240 participants
- Registry
-
NCT02625870
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02625870. Randomized; double masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
- Acronym
- OMEELVHT
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- Omega-3-Acid Ethyl Esters 90 Soft Capsules
- Intervention (Drug)
- Corn Oil
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct02625870- Content hash
416504c7a2d325287b3c52468443fd5290c25c73635c568ac93bdf5bc0337a4c